As the United States begins its first shipments, the COVID-19 vaccine roll-out raises hopes for a swift recovery from the global coronavirus-induced economic downturn.
Optimism about COVID-19 promising vaccine updates has not faded away yet amid growing expectations of more government stimulus soon for coronavirus-hit economies.
The economic damage from the COVID-19 pandemic knocked back sentiment at the end of a grand November for markets undermining safe-havens.
Investors place their hopes for economic recovery on early rollout coronavirus vaccines, even as the world faces surging cases and delays to fresh U.S. stimulus.
Worries about rising infection numbers and risks to the fragile global economic recovery made global markets cautious.